A look at the current reimbursement environment for continuous glucose monitoring (CGM): understanding the fundamentals.
As reimbursement continues to decline for diabetes management technologies and practice overhead continues to rise, it is becoming increasingly important to understand the current reimbursement environment for new technological innovations in diabetes care. The current environment demands a strong partnership among providers, key stakeholder groups, and industry to advocate for favorable coding, coverage, and payment of these new advancements, in order to improve accessibility to the patient. This article describes trends in the current reimbursement environment for continuous glucose monitoring and provides recommendations on how to maneuver through the intricacies of coding and coverage related to this emerging category of glucose monitoring.
Telgener
Patty Curoe
PC
Global Therapy Access, Medtronic Diabetes.
Lowe
Serena
S